FILINGS
| BCRX 0000882796 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2018-06-20 | SC 13D/A | View Document | |
| 2018-06-11 | 425 | 425 | View Document |
| 2018-06-11 | 425 | 425 | View Document |
| 2018-06-07 | 425 | 425 | View Document |
| 2018-06-07 | 425 | 425 | View Document |
| 2018-06-07 | 425 | 425 | View Document |
| 2018-06-06 | CT ORDER | View Document | |
| 2018-06-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-06-05 | 425 | 425 | View Document |
| 2018-06-04 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-06-04 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-05-30 | DEFM14A | DEFM14A | View Document |
| 2018-05-24 | 8-K | FORM 8-K | View Document |
| 2018-05-21 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-05-17 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-05-10 | DEFA14A | DEFA14A | View Document |
| 2018-05-10 | DEF 14A | DEFINITIVE PROXY STATEMENT | View Document |
| 2018-05-09 | 10-Q | FORM 10-Q | View Document |
| 2018-05-09 | 425 | 425 | View Document |
| 2018-05-08 | 425 | FORM 425 FOR BIOCRYST PHARMACEUTICALS INC | View Document |
| 2018-05-08 | 425 | FORM 425 FOR BIOCRYST PHARMACEUTICALS INC | View Document |
| 2018-05-08 | 8-K | FORM 8-K | View Document |
| 2018-05-01 | 8-K | FORM 8-K | View Document |
| 2018-04-10 | 425 | 425 | View Document |
| 2018-04-10 | 425 | 425 | View Document |
| 2018-04-06 | CT ORDER | View Document | |
| 2018-04-02 | 425 | 425 | View Document |
| 2018-04-02 | 425 | 425 | View Document |
| 2018-04-02 | SC 13D | View Document | |
| 2018-04-02 | 425 | 425 | View Document |
| 2018-04-02 | 425 | 425 | View Document |
| 2018-03-29 | DEFM14A | DEFM14A | View Document |
| 2018-03-27 | 10-K/A | FORM 10-K/A | View Document |
| 2018-03-22 | 425 | 425 | View Document |
| 2018-03-22 | 425 | 425 | View Document |
| 2018-03-15 | 8-K | FORM 8-K | View Document |
| 2018-03-12 | 10-K | FORM 10-K | View Document |
| 2018-03-08 | 425 | 425 | View Document |
| 2018-03-08 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-03-07 | 425 | 425 | View Document |
| 2018-03-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-03-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-03-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-03-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-02-28 | 425 | View Document | |
| 2018-02-28 | 8-K | FORM 8-K | View Document |
| 2018-02-27 | 425 | 425 | View Document |
| 2018-02-27 | 425 | 425 | View Document |
| 2018-02-27 | 8-K | 8-K | View Document |
| 2018-02-27 | 425 | 425 | View Document |
| 2018-02-27 | 425 | 425 | View Document |
| 2018-02-27 | 425 | 425 | View Document |
| 2018-02-27 | 425 | 425 | View Document |
| 2018-02-23 | 425 | 425 | View Document |
| 2018-02-22 | 425 | FORM 425 FOR BIOCRYST PHARMACEUTICALS INC | View Document |
| 2018-02-22 | 425 | 425 | View Document |
| 2018-02-22 | 425 | 425 | View Document |
| 2018-02-20 | 425 | 425 | View Document |
| 2018-02-16 | SC 13D | View Document | |
| 2018-02-14 | SC 13G | SC 13G | View Document |
| 2018-02-14 | SC 13G/A | SC 13G/A | View Document |
| 2018-02-14 | SC 13G/A | View Document | |
| 2018-02-14 | SC 13G/A | View Document | |
| 2018-02-14 | SC 13G/A | SC 13G/A | View Document |
| 2018-02-13 | SC 13G/A | AMENDMENT NO. 1 | View Document |
| 2018-02-12 | SC 13G | JANUS HENDERSON GROUP OWNS OVER 5% | View Document |
| 2018-02-08 | SC 13G | View Document | |
| 2018-01-29 | SC 13G/A | View Document | |
| 2018-01-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-01-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-01-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-01-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-01-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-01-23 | 425 | 425 | View Document |
| 2018-01-22 | 425 | 425 | View Document |
| 2018-01-22 | 425 | 425 | View Document |
| 2018-01-22 | 425 | 425 | View Document |
| 2018-01-22 | 425 | 425 | View Document |
| 2018-01-22 | 425 | 425 | View Document |
| 2018-01-22 | 8-K | 8-K | View Document |
| 2018-01-22 | 425 | 8-K | View Document |
| 2018-01-05 | 8-K | FORM 8-K | View Document |
| 2018-01-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-01-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-01-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-01-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2018-01-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-12-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-12-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-12-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-12-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-12-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-12-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-12-12 | EFFECT | View Document | |
| 2017-12-08 | CORRESP | View Document | |
| 2017-12-04 | S-3/A | FORM S-3/A | View Document |
| 2017-12-04 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-12-04 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-11-15 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-11-08 | S-3 | FORM S-3 | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.
